Jul23 FDA Approves KERENDIA (Finerenone) to Reduce the Risk of Sustained EGFR Decline, End Stage Kidney Disease, Cardiovascular Death, Non-Fatal Myocardial Infarction, and Hospitalization for Heart Failure in Adult Patients with CKD Associated with T2D
On July 9, 2021, the US Food and Drug Administration (FDA) approved KERENDIA (finerenone) to reduce ...
Jul23 FDA and Duke-Margolis Announce a Public Workshop Entitled “Pharmacodynamic Biomarkers for Biosimilar Development and Approval” for September 20 – 21, 2021
The US Food and Drug Administration (FDA) in collaboration with Duke-Margolis will host a two-day ...
Jul16 FDA News: Issue 22, July 2021
FDA Approves RYLAZE [Asparaginase Erwinia Chrysanthemi (recombinant)-rywn] for the Treatment of ALL ...
Jul01 ASCPT News: July 2021
Stay up to date on the latest in clinical pharmacology and translational science.
Jul01 I am ASCPT: Qi Liu
Qi Liu, PhD, Senior Science Advisor, US Food and Drug Administration, Silver Spring, Maryland
Jul01 I am ASCPT: Daniel Rosenbloom
Daniel Rosebloom, PhD, Associate Principal Scientist, Merck & Co., Brooklyn, New York
Jul01 I am ASCPT: Joseph Jilek
Joseph Jilek, PhD, Postdoctoral Student, University of Arizona, Tucson, Arizona
Jul01 I am ASCPT: João A. Abrantes
João A. Abrantes, PhD, Senior Scientist, F. Hoffman-La Roche, Basel, Switzerland
Jun21 FDA News: FDA Approves TEMBEXA (Brincidofovir) for the Treatment of Human Smallpox Disease in Adult and Pediatric Patients Including Neonates
On June 4, 2021, the US Food and Drug Administration (FDA) approved TEMBEXA (brincidofovir) tablet...
Jun21 FDA News: FDA Announces Availability of a Final Guidance Titled COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry
On February 22, 2021, the US Food and Drug Administration (FDA) announced the availability of a fin...